Haleon PLC
Company Profile
Business description
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Contact
The Heights
Building 5, First Floor
Surrey
WeybridgeKT13 0NY
GBRT: +44 1932959500
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
24,622
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,768.60 | 1.60 | -0.02% |
CAC 40 | 7,843.43 | 38.76 | 0.50% |
DAX 40 | 24,370.59 | 94.11 | 0.39% |
Dow JONES (US) | 42,427.74 | 91.90 | -0.22% |
FTSE 100 | 8,826.21 | 24.92 | 0.28% |
HKSE | 23,906.97 | 252.94 | 1.07% |
NASDAQ | 19,460.49 | 61.53 | 0.32% |
Nikkei 225 | 37,554.49 | 192.96 | -0.51% |
NZX 50 Index | 12,577.15 | 82.44 | 0.66% |
S&P 500 | 5,970.81 | 0.44 | 0.01% |
S&P/ASX 200 | 8,538.90 | 2.90 | -0.03% |
SSE Composite Index | 3,384.10 | 7.90 | 0.23% |